A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
Clinical trial NCT04104893 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04104893
- Sponsor
- VA Office of Research and Development
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-20
- Primary completion
- 2026-02-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.